Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析

◆英語タイトル:Chenguang Biotech Group Co Ltd (300138) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDING347582FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Ingredients
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Chenguang Biotech Group Co Ltd (300138) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Chenguang Biotech Group Co Ltd (Chenguang) manufactures, supplies, and exports agricultural products and herb extracts. The company’s product portfolio comprises paprika oleoresin, marigold oleoresin, refined cottonseed oil, cottonseed oil, grape seed oil, walnut oil, dephenolized cottonseed protein, flaxseed oil, natural lutein, safflower seed oil and turmeric. It also offers capsicum oleoresins, sichuan pepper oil, pepper oleoresin, ginger extract, cumin oil, lycopene, lutein, green coffee bean extract, grape seed extract, curcumin, inulin, and stevioside. Chenguang serves to food, beverages, animal feed, pharmaceutical, cosmetics and healthcare industries. It exports to Europe, the Americas, Australia, Japan, South Korea, South Asia, Southeast Asia, and Africa. The company is headquartered in Quzhou County, Hebei, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Chenguang Biotech Group Co Ltd – Key Facts
Chenguang Biotech Group Co Ltd – Key Employees
Chenguang Biotech Group Co Ltd – Major Products and Services
Chenguang Biotech Group Co Ltd – History
Chenguang Biotech Group Co Ltd – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Chenguang Biotech Group Co Ltd – Business Description
Chenguang Biotech Group Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Chenguang Biotech Group Co Ltd – Strengths
Chenguang Biotech Group Co Ltd – Weaknesses
Chenguang Biotech Group Co Ltd – Opportunities
Chenguang Biotech Group Co Ltd – Threats
Chenguang Biotech Group Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Chenguang Biotech Group Co Ltd, Recent Deals Summary
Section 4 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Chenguang Biotech Group Co Ltd, Key Facts
Chenguang Biotech Group Co Ltd, Key Employees
Chenguang Biotech Group Co Ltd, Major Products and Services
Chenguang Biotech Group Co Ltd, History
Chenguang Biotech Group Co Ltd, Key Competitors
Chenguang Biotech Group Co Ltd, Ratios based on current share price
Chenguang Biotech Group Co Ltd, Annual Ratios
Chenguang Biotech Group Co Ltd, Annual Ratios (Cont...1)
Chenguang Biotech Group Co Ltd, Annual Ratios (Cont...2)
Chenguang Biotech Group Co Ltd, Interim Ratios
Chenguang Biotech Group Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Chenguang Biotech Group Co Ltd (300138):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arsenal Holdings plc:企業の戦略的SWOT分析
    Arsenal Holdings plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • MS Amlin plc:企業の戦略的SWOT分析
    MS Amlin plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Bank of Shanghai Co., Ltd.:企業の戦略・SWOT・財務情報
    Bank of Shanghai Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank of Shanghai Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mid-America Apartment Communities Inc (MAA):企業の財務・戦略的SWOT分析
    Summary Mid-America Apartment Communities Inc (MAA) is a real estate investment company that operates apartment homes. The company is engaged in property development, property management, redevelopment, acquisition, sales, marketing and financing. MAA provides web-based and technology driven support …
  • Banca Dello Stato Del Cantone Ticino
    Banca Dello Stato Del Cantone Ticino - Strategy, SWOT and Corporate Finance Report Summary Banca Dello Stato Del Cantone Ticino - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • H.I.S. Co., Ltd.:企業の戦略・SWOT・財務情報
    H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Aurinia Pharmaceuticals Inc (AUP):企業の財務・戦略的SWOT分析
    Summary Aurinia Pharmaceuticals Inc (Aurinia Pharmaceuticals), formerly Isotechnika Pharma Inc, is a clinical stage biopharmaceutical company which develops and commercializes therapies for the treatment of diseases with high unmet medical need. Its pipeline products include Voclosporin, is an inves …
  • Implanet SA (IMPL):医療機器:M&Aディール及び事業提携情報
    Summary Implanet SA (Implanet) is a medical device company that designs, manufactures and markets orthopaedic products. The company offers spine, knee and arthroscopy products. Its spine products are used for the treatment of spinal disorders and spinal fusion surgery. Implanet offers resorbable anc …
  • Ecolab Inc (ECL):石油・ガス:M&Aディール及び事業提携情報
    Summary Ecolab Inc (Ecolab) provides water, hygiene and energy technologies and services. It offers solutions and services such as cleaning and sanitizing programs and products, pest elimination services, and equipment maintenance and repair services. The company caters to foodservice, food and beve …
  • Asian Citrus Holdings Ltd (73):企業の財務・戦略的SWOT分析
    Asian Citrus Holdings Ltd (73) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • NextCare Holdings Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NextCare Holdings Inc (NextCare) is a healthcare service provider that offer urgent care services, walk-ins medical clinics, general medical care and occupational medicine. The center’s urgent care services include DOT physicals, illness treatment, minor injury care, pediatrics, X-rays, immu …
  • EpiVax Inc-製薬・医療分野:企業M&A・提携分析
    Summary EpiVax Inc (EpiVax) is an immunology company which develops analytical capabilities in the field of computational immunology. Its product pipeline includes Tregitopes; deimmunization projects including deimmunized botox and deimmunized FVIII; and biodefense vaccines. Tregitopes are linear se …
  • Services Group of America:企業の戦略・SWOT・財務分析
    Services Group of America - Strategy, SWOT and Corporate Finance Report Summary Services Group of America - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Alfred E. Tiefenbacher GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報
    Summary Alfred E. Tiefenbacher GmbH & Co KG (AET) is an independent pharmaceutical company that focuses on the development of active pharmaceuticals ingredients. It offers products in the forms of tablets, capsules, oral solution, patches, long acting injectables, ophthalmic solution and inhaled the …
  • ERG Renew SpA-エネルギー分野:企業M&A・提携分析
    Summary ERG Renew S.p.A. (ERG Renew), formerly Entad S.p.A., a subsidiary of ERG S.p.A, is a power company that generates electricity from renewable sources. The company generates electricity mainly through wind. ERG Renew and its subsidiaries operate in Italy, France, Bulgaria/Romania, Germany, and …
  • Air France-KLM SA:戦略・SWOT・企業財務分析
    Air France-KLM SA - Strategy, SWOT and Corporate Finance Report Summary Air France-KLM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • SK Gas Co Ltd (018670):企業の財務・戦略的SWOT分析
    Summary SK Gas Co Ltd (SK Gas), a subsidiary of SK Chemicals Co Ltd, is an oil and gas company that supplies liquefied petroleum gas. It operates through its business divisions such as LPG marketing, global LPG trading, LPG import terminal, propane de-hydrogenation and tank terminal. It offers tank …
  • Promore Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Promore Pharma AB (Promore), formerly Pergamum AB is a biopharmaceutical company that develops peptide-based product candidates for local and topical treatment of infections and wounds. The company’s pipeline products include LL-37 and PXL01 therapeutic peptides. Its PXL01 is used for the pr …
  • Nord Gold SE:企業の戦略・SWOT・財務分析
    Nord Gold SE - Strategy, SWOT and Corporate Finance Report Summary Nord Gold SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Reata Pharmaceuticals Inc (RETA):企業の財務・戦略的SWOT分析
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆